vinburnine
This page covers all vinburnine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3.
Targets
Phase 2 pipeline (1)
- Vincamone · Cardiovascular
Vincamone works by binding to the muscarinic acetylcholine receptor M3, which is involved in various physiological processes.
Patent intelligence
- vinburnine patent landscape — aggregated cliff calendar, attackable patents, originator estates